Literature DB >> 20971769

Knockout of insulin receptors in cardiomyocytes attenuates coronary arterial dysfunction induced by pressure overload.

J David Symons1, Ping Hu, Ying Yang, Xiaohui Wang, Quan-Jiang Zhang, Adam R Wende, Crystal L Sloan, Sandra Sena, E Dale Abel, Sheldon E Litwin.   

Abstract

Ablating insulin receptors in cardiomyocytes causes subendocardial fibrosis and left ventricular (LV) dysfunction after 4 wk of transverse aortic constriction (TAC). To determine whether these maladaptive responses are precipitated by coronary vascular dysfunction, we studied mice with cardiomyocyte-restricted knock out of insulin receptors (CIRKO) and wild-type (WT) TAC mice before the onset of overt LV dysfunction. Two weeks of TAC produced comparable increases (P < 0.05 vs. respective sham) in heart weight/body weight (mg/g) in WT-TAC (8.03 ± 1.14, P < 0.05 vs. respective sham) and CIRKO-TAC (7.76 ± 1.25, P < 0.05 vs. respective sham) vs. WT-sham (5.64 ± 0.11) and CIRKO-sham (4.64 ± 0.10) mice. In addition, 2 wk of TAC were associated with similar LV geometry and function (echocardiography) and interstitial fibrosis (picrosirius red staining) in CIRKO and WT mice. Responses to acetylcholine (ACh), N(G)-monomethyl-L-arginine (l-NMMA), and sodium nitroprusside (SNP) were measured in coronary arteries that were precontracted to achieve ∼70% of maximal tension development using the thromboxane A(2) receptor mimetic U-46619 (∼3 × 10(-6) M). ACh-evoked vasorelaxation was absent in WT-TAC but was present in CIRKO-TAC albeit reduced relative to sham-operated animals. l-NMMA-evoked tension development was similar in vessels from CIRKO-TAC mice but was lower (P < 0.05) in WT-TAC animals vs. the respective sham-operated groups, and SNP-evoked vasorelaxation was similar among all mice. Thus estimates of stimulated and basal endothelial nitric oxide release were better preserved in CIRKO vs. WT mice in response to 2 wk of TAC. These findings indicate that maladaptive LV remodeling previously observed in CIRKO-TAC mice is not precipitated by coronary artery dysfunction, because CIRKO mice exhibit compensatory mechanisms (e.g., increased eNOS transcript and protein) to maintain coronary endothelial function in the setting of pressure overload.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20971769      PMCID: PMC3023253          DOI: 10.1152/ajpheart.01200.2009

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  26 in total

1.  Quercetin-supplemented diets lower blood pressure and attenuate cardiac hypertrophy in rats with aortic constriction.

Authors:  Thunder Jalili; Justin Carlstrom; Sun Kim; David Freeman; Huifeng Jin; Tzu-Ching Wu; Sheldon E Litwin; J David Symons
Journal:  J Cardiovasc Pharmacol       Date:  2006-04       Impact factor: 3.105

2.  Vascular dysfunction produced by hyperhomocysteinemia is more severe in the presence of low folate.

Authors:  J David Symons; John C Rutledge; U Simonsen; Roshny A Pattathu
Journal:  Am J Physiol Heart Circ Physiol       Date:  2005-09-02       Impact factor: 4.733

3.  Reducing arginase activity via dietary manganese deficiency enhances endothelium-dependent vasorelaxation of rat aorta.

Authors:  Jodi L Ensunsa; J David Symons; Louise Lanoue; Heather R Schrader; Carl L Keen
Journal:  Exp Biol Med (Maywood)       Date:  2004-12

4.  A quercetin supplemented diet does not prevent cardiovascular complications in spontaneously hypertensive rats.

Authors:  Justin Carlstrom; J David Symons; Tzu Ching Wu; Richard S Bruno; Sheldon E Litwin; Thunder Jalili
Journal:  J Nutr       Date:  2007-03       Impact factor: 4.798

5.  Cardiac hypertrophy caused by peroxisome proliferator- activated receptor-gamma agonist treatment occurs independently of changes in myocardial insulin signaling.

Authors:  Sandra Sena; Isaac R Rasmussen; Adam R Wende; Alfred P McQueen; Heather A Theobald; Nicole Wilde; Renata Oliveira Pereira; Sheldon E Litwin; Joel P Berger; E Dale Abel
Journal:  Endocrinology       Date:  2007-09-06       Impact factor: 4.736

Review 6.  Diabetic cardiomyopathy.

Authors:  F S Fein; E H Sonnenblick
Journal:  Cardiovasc Drugs Ther       Date:  1994-02       Impact factor: 3.727

Review 7.  Insulin action and insulin resistance in vascular endothelium.

Authors:  Ranganath Muniyappa; Michael J Quon
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2007-07       Impact factor: 4.294

8.  A conserved role for phosphatidylinositol 3-kinase but not Akt signaling in mitochondrial adaptations that accompany physiological cardiac hypertrophy.

Authors:  Brian T O'Neill; Jaetaek Kim; Adam R Wende; Heather A Theobald; Joseph Tuinei; Jonathan Buchanan; Aili Guo; Vlad G Zaha; Don K Davis; John C Schell; Sihem Boudina; Benjamin Wayment; Sheldon E Litwin; Tetsuo Shioi; Seigo Izumo; Morris J Birnbaum; E Dale Abel
Journal:  Cell Metab       Date:  2007-10       Impact factor: 27.287

Review 9.  Cardiovascular actions of insulin.

Authors:  Ranganath Muniyappa; Monica Montagnani; Kwang Kon Koh; Michael J Quon
Journal:  Endocr Rev       Date:  2007-05-24       Impact factor: 19.871

10.  Primer3Plus, an enhanced web interface to Primer3.

Authors:  Andreas Untergasser; Harm Nijveen; Xiangyu Rao; Ton Bisseling; René Geurts; Jack A M Leunissen
Journal:  Nucleic Acids Res       Date:  2007-05-07       Impact factor: 16.971

View more
  12 in total

Review 1.  The link between metabolic abnormalities and endothelial dysfunction in type 2 diabetes: an update.

Authors:  Hanrui Zhang; Kevin C Dellsperger; Cuihua Zhang
Journal:  Basic Res Cardiol       Date:  2011-12-22       Impact factor: 17.165

2.  Cytosolic, but not mitochondrial, oxidative stress is a likely contributor to cardiac hypertrophy resulting from cardiac specific GLUT4 deletion in mice.

Authors:  Yan Li; Adam R Wende; Orathai Nunthakungwan; Yujia Huang; Eric Hu; Huifeng Jin; Sihem Boudina; E Dale Abel; Thunder Jalili
Journal:  FEBS J       Date:  2012-01-09       Impact factor: 5.542

3.  Nrf2 deficiency prevents reductive stress-induced hypertrophic cardiomyopathy.

Authors:  Sankaranarayanan Kannan; Vasanthi R Muthusamy; Kevin J Whitehead; Li Wang; Aldrin V Gomes; Sheldon E Litwin; Thomas W Kensler; E Dale Abel; John R Hoidal; Namakkal S Rajasekaran
Journal:  Cardiovasc Res       Date:  2013-06-12       Impact factor: 10.787

4.  The absence of insulin signaling in the heart induces changes in potassium channel expression and ventricular repolarization.

Authors:  Angelica Lopez-Izquierdo; Renata O Pereira; Adam R Wende; Bonnie B Punske; E Dale Abel; Martin Tristani-Firouzi
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-12-27       Impact factor: 4.733

5.  Impact of age on the vasodilatory function of human skeletal muscle feed arteries.

Authors:  Song-Young Park; Stephen J Ives; Jayson R Gifford; Robert H I Andtbacka; John R Hyngstrom; Van Reese; Gwenael Layec; Leena P Bharath; John D Symons; Russell S Richardson
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-11-20       Impact factor: 4.733

Review 6.  Insulin signaling in the heart.

Authors:  E Dale Abel
Journal:  Am J Physiol Endocrinol Metab       Date:  2021-05-31       Impact factor: 5.900

7.  Ceramide mediates vascular dysfunction in diet-induced obesity by PP2A-mediated dephosphorylation of the eNOS-Akt complex.

Authors:  Quan-Jiang Zhang; William L Holland; Lloyd Wilson; Jason M Tanner; Devin Kearns; Judd M Cahoon; Dix Pettey; Jason Losee; Bradlee Duncan; Derrick Gale; Christopher A Kowalski; Nicholas Deeter; Alexandrea Nichols; Michole Deesing; Colton Arrant; Ting Ruan; Christoph Boehme; Dane R McCamey; Janvida Rou; Kapil Ambal; Krishna K Narra; Scott A Summers; E Dale Abel; J David Symons
Journal:  Diabetes       Date:  2012-05-14       Impact factor: 9.461

8.  Soluble (pro)renin receptor induces endothelial dysfunction and hypertension in mice with diet-induced obesity via activation of angiotensin II type 1 receptor.

Authors:  Ziwei Fu; Fei Wang; Xiyang Liu; Jiajia Hu; Jiahui Su; Xiaohan Lu; Aihua Lu; Jae Min Cho; J David Symons; Chang-Jiang Zou; Tianxin Yang
Journal:  Clin Sci (Lond)       Date:  2021-03-26       Impact factor: 6.876

9.  Vasoreactivity of the Murine External Jugular Vein and Carotid Artery.

Authors:  Jae Min Cho; Yan-Ting Shiu; J David Symons; Timmy Lee
Journal:  J Vasc Res       Date:  2020-06-15       Impact factor: 2.045

10.  Ceramide-Initiated Protein Phosphatase 2A Activation Contributes to Arterial Dysfunction In Vivo.

Authors:  Leena P Bharath; Ting Ruan; Youyou Li; Anindita Ravindran; Xin Wan; Jennifer Kim Nhan; Matthew Lewis Walker; Lance Deeter; Rebekah Goodrich; Elizabeth Johnson; Derek Munday; Robert Mueller; David Kunz; Deborah Jones; Van Reese; Scott A Summers; Pon Velayutham Anandh Babu; William L Holland; Quan-Jiang Zhang; E Dale Abel; J David Symons
Journal:  Diabetes       Date:  2015-08-07       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.